- Home
- POLA vs ADXN Comparison
POLA vs ADXN Comparison
Compare POLA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- ADXN
- Stock Information
- Founded
- POLA 1979
- ADXN 2002
- Country
- POLA United States
- ADXN Switzerland
- Employees
- POLA N/A
- ADXN N/A
- Industry
- POLA Industrial Machinery/Components
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- ADXN Health Care
- Exchange
- POLA Nasdaq
- ADXN Nasdaq
- Market Cap
- POLA 8.7M
- ADXN 8.5M
- IPO Year
- POLA 2016
- ADXN N/A
- Fundamental
- Price
- POLA $4.87
- ADXN N/A
- Analyst Decision
- POLA
- ADXN
- Analyst Count
- POLA 0
- ADXN 0
- Target Price
- POLA N/A
- ADXN N/A
- AVG Volume (30 Days)
- POLA 55.5K
- ADXN 67.2K
- Earning Date
- POLA 11-13-2025
- ADXN 11-21-2025
- Dividend Yield
- POLA N/A
- ADXN N/A
- EPS Growth
- POLA N/A
- ADXN N/A
- EPS
- POLA N/A
- ADXN N/A
- Revenue
- POLA $11,967,000.00
- ADXN $210,347.00
- Revenue This Year
- POLA N/A
- ADXN $86.57
- Revenue Next Year
- POLA N/A
- ADXN N/A
- P/E Ratio
- POLA N/A
- ADXN N/A
- Revenue Growth
- POLA 0.14
- ADXN N/A
- 52 Week Low
- POLA $1.53
- ADXN $6.51
- 52 Week High
- POLA $5.59
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- POLA 70.96
- ADXN 53.43
- Support Level
- POLA $3.20
- ADXN $8.68
- Resistance Level
- POLA $5.59
- ADXN $9.41
- Average True Range (ATR)
- POLA 0.46
- ADXN 0.85
- MACD
- POLA 0.12
- ADXN -0.05
- Stochastic Oscillator
- POLA 63.05
- ADXN 26.23
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.